Related Experiment Video
Updated: Feb 16, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK
Yong-Jian Wang1, Zi-Feng Zhang1, Shao-Hua Fan1
1Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China.
Abstract:
We investigated the involvement of microRNA-433 (miR-433) in the proliferation, migration, and invasiveness of oral squamous cell carcinoma (OSCC). Totally 108 OSCC tissues and adjacent normal tissues from patients with OSCC were collected. Also, transplanted tumor formation experiment in nude mice was conducted to verify the effect of miR-433 and FAK on subcutaneous transplanted tumor. The CD44+ stem cell from SCC-9 were collected and assigned into the blank, miR-433 mimics, mimics control, miR-433 inhibitors, inhibitors control, siFAK and miR-433 inhibitors + siFAK groups. The qRT-PCR and western blotting were used to detect miR-433, FAK, ERK, MEK, pERK and pMEK after transfection. Flow cytometry, MTT assay, scratch test and Transwell assay were performed to determine the cell proportion, growth, migration and invasion of SCC-9 cells. In cell line SCC-9, expression of CD133, Oct-4, and BIM-1 was greater in CD44+ cells than CD44- cells, indicating that CD44+ cells had characteristics of tumor stem cells. Expression of FAK, ERK, MEK, p-ERK and p-MEK was decreased in tumor tissues from the CD44-, miR-433, and siFAK groups. Expression of MiR-433 mRNA was elevated, while levels of FAK, ERK, MEK, p-ERK, and p-MEK mRNA were all decreased in the miR-433 mimics group. In the miR-433 mimics and siFAK groups, cell proliferation, migration, and invasion were all decreased, while the opposite trends were seen in the miR-433 inhibitor group. These results indicate that miR-433 downregulates FAK through the ERK/MAPK signaling pathway to inhibit the proliferation, migration, and invasiveness of SCC-9 OSCC cells.
Insights
MicroRNA-433 (miR-433) inhibits oral squamous cell carcinoma (OSCC) growth by downregulating focal adhesion kinase (FAK) via the ERK/MAPK pathway. This finding offers potential therapeutic targets for OSCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with complex regulatory mechanisms.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- Identifying key molecular players like miR-433 is vital for understanding OSCC pathogenesis.
Purpose of the Study:
- To investigate the role of microRNA-433 (miR-433) in the proliferation, migration, and invasiveness of oral squamous cell carcinoma (OSCC).
- To elucidate the molecular mechanism by which miR-433 influences OSCC progression, focusing on the focal adhesion kinase (FAK)/ERK/MAPK signaling pathway.
- To assess the therapeutic potential of modulating miR-433 in OSCC.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting to measure miRNA and protein expression levels.
- Cellular assays including flow cytometry, MTT assay, scratch test, and Transwell assay to evaluate cell proliferation, migration, and invasion.
- In vivo studies using a subcutaneous transplanted tumor model in nude mice to assess the effect of miR-433 and FAK.
- Transfection of SCC-9 cells with miR-433 mimics, inhibitors, and small interfering RNA (siFAK) to manipulate gene expression.
Main Results:
- miR-433 expression was elevated in OSCC tissues and miR-433 mimics reduced OSCC cell proliferation, migration, and invasion.
- miR-433 mimics decreased the expression of FAK, ERK, MEK, p-ERK, and p-MEK, while miR-433 inhibitors showed opposite effects.
- Downregulation of FAK by miR-433 occurred through the ERK/MAPK signaling pathway, inhibiting tumor stem cell characteristics and subcutaneous tumor formation.
- CD44+ cells exhibited characteristics of tumor stem cells, and FAK, ERK, MEK, p-ERK, and p-MEK were decreased in CD44-, miR-433, and siFAK groups.
Conclusions:
- miR-433 acts as a tumor suppressor in OSCC by inhibiting proliferation, migration, and invasiveness.
- miR-433 exerts its effects by downregulating FAK expression through the ERK/MAPK signaling pathway.
- Modulating miR-433 and FAK represents a potential therapeutic strategy for OSCC.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Abnormal Proliferation

